N. Regamey (Bern, Switzerland), I. Balfour-Lynn (London, United Kingdom), B. Linnane (Limerick, Ireland), H. Janssens (Rotterdam, The Netherlands)
LATE-BREAKING ABSTRACT: Socio-economic status does not influence lung function decline in children with cystic fibrosis in Australia
L. Welsh, S. Ranganathan, C. Robertson (Melbourne, Australia)
|   |
p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients
S. Gartner, J. de Gracia, A. Moreno, A. Alvarez, T. Casals, O. Asensi, S. Rovira, I. de Mir, A. Torrent, M. Bosque (Barcelona, Sabadell, Spain)
| |
Sinonasal mucoceles in cystic fibrosis
M. Di Cicco, N. Luca, L. Pignataro, C. Colombo (Milan, Italy)
| |
Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
M. Todorova, N. Genkova, B. Marinov, S. Mandadzhieva, M. Bosheva, S. Kostianev (Plovdiv, Bulgaria)
| |
Delivery of dornase alfa via breath-actuated nebulizer: In-vitro measures of performance
J. Suggett, J. Mitchell, H. Schneider, R. Ali, M. Nagel (London, Canada)
| |
Delivered dose of colistimethate sodium via 3 nebulizers; a comparison of bioassay and HPLC assay results
A. Metcalf, S. Byrne, D. Jeffrey, R. Hatley (Chichester, United Kingdom)
| |
Use of an electronic monitoring system to generate objective information on patients’ adherence to taking treatments of a novel inhaled tobramycin solution
D. Sands, E. Sapiejka, H. Mazurek, G. Gaszczyk (Warsaw, Gdansk, Rabka, Karpacz, Poland)
| |
Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia
V. Chikunov, N. Ilienkova, T. Elizareva (Krasnoyarsk, Russian Federation)
| |
Genetic characterization of cystic fibrosis patients in Portugal
L. Pereira, P. Azevedo, J. Cavaco, M. Felix, F. Gamboa, A. Amorim, L. Vaz, H. Rocha, J. Goncalves, C. Freitas, C. Barreto (Lisboa, Coimbra, Porto, Ponta Delgada, Funchal, Portugal)
| |
Development of lung radiological findings of cystic fibrosis patients under 6 years old
C. Ibiapina, J. Pedrosa, C. Alvim, P. Camargos (Belo Horizonte, Brazil)
| |
Cystic fibrosis and arthritis in children
V. D. Comanici, I. V. Stan, M. Craiu, A. M. Vasile (Bucharest, Romania)
| |
Vitamin D serum level and pulmonary exacerbations in children with cystic fibrosis
T. Butenko, J. Rodman, M. Praprotnik, M. Aldeco, D. Lepej, U. Krivec (Ljubljana, Slovenia)
| |
Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment?
A. Teper, G. Villagra, S. Fili, S. Lubovich, S. Zaragoza, V. Rodriguez (Buenos Aires, Argentina)
| |
Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis
J. Rodman, T. Butenko, A. Kotnik, K. Seme, U. Krivec (Ljubljana, Slovenia)
| |
Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis
A. Amaddeo, M. Bramuzzo, S. Saletta, F. Poli (Trieste, Gorizia, Italy)
| |
Successful eradication of methicillin-resistant staphylococcus aureus in chronically colonized cystic fibrosis patients
E. Vanderhelst, E. De Wachter, J. Willekens, W. Vincken, A. Malfroot (Brussels, Belgium)
| |
Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age
M. Zampoli, B. Morrow, H. Carrara, H. Zar, A. Whitelaw, A. Westwood (Cape Town, South Africa)
| |
Role of lobectomy in cystic fibrosis
S. Sheikh, J. Pitts, N. Ryan-Wenger, A. Patel, K. Mccoy (Columbus, United States Of America)
| |